Avelumab in G3 NEC

Clinical trial NCT03278405 · COMPLETED

Trial details

NCT number: NCT03278405
Sponsor: Sunnybrook Health Sciences Centre
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Carcinoma

Start date: 2017-11-15
Primary completion: 2019-08-09
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.